Navigation Links
Stemedica's President Delivers Keynote Address At Swiss-Russian Forum

Dr. Nikolai Tankovich, President of Stemedica, delivered the keynote speech at the Crossing Visions Summit held in Moscow from September 14th - 16th. His presentation at a forum of top Russian and Swiss political, economic and business leaders featured advances in stem cell technology.

San Diego, CA (PRWEB) -- Dr. Nikolai Tankovich, President of Stemedica, delivered the keynote speech at the Crossing Visions Summit held in Moscow from September 14th - 16th. His presentation at a forum of top Russian and Swiss political, economic and business leaders featured advances in stem cell technology. The Swiss delegation invited Dr. Tankovich, not only for his scientific expertise, but as an example of an on-going scientific collaboration that Stemedica has established between Switzerland and Russia.

"We are delighted that Dr. Tankovich has accepted our invitation to be the key note speaker at our collaborative forum in Moscow. His expertise in stem cells places him among the premier researchers and clinicians in regenerative medicine," stated Eric Maire, Senior Director Economic Development, State of Vaud, Switzerland.

At the forum, a delegation of over 100 leaders from Switzerland's government, business and biotech sectors met with over 300 of Russia's executives and policy makers. The purpose of the forum was to further commercial relationships between the two countries. During the forum, a number of collaborative agreements between the two countries were signed paving the way for new forms of long-term, forward-looking cooperative relationships.

"We are especially pleased with the outcome of this forum and believe it has been an example of the intensification of the ties that have, and continue to, bind Russia to Switzerland," said Walter B. Gyger, Ambassador of Switzerland to the Russian Federation. The Ambassador further stated, "We are very pleased that Stemedica, a prime example of collaboration between Switzerland and Russia, has chosen Switzerland for its International Headquarters. Its advancement and leadership in the stem cell industry is very impressive and we look forward to supporting them in their research, development and manufacturing efforts."

"I am truly honored to have been selected by the Swiss Government to present Stemedica's cutting edge stem cell technologies to this conference on innovation and science," said Dr. Tankovich. "The research and development collaboration between Russia and Switzerland fits Stemedica's tactical and strategic initiatives as we already have on-going business and research operations in these two great countries as well as in important marketplace leaders like the United States and Korea. We're delighted with the enthusiasm and long-term commitments being made at this Forum as well as the media interest that this event has generated here in Russia. Such interest and support bodes well for the entire stem cell industry."

Maynard A. Howe, PhD, Stemedica's Vice Chairman and CEO was also in attendance at the Summit. Dr. Howe emphasized the importance of these strategic relationships. "Stemedica is committed to working with the world's best and brightest as we work to build a better future for the stem cell industry as well as those who will benefit from our collective efforts. This type of alliance fosters the kind of technology sharing in the biotech and pharmaceutical industries that will soon be changing the lives of millions suffering from debilitating diseases and conditions."

Dr. Tankovich and other Stemedica colleagues will continue to present at national and international conferences like the Crossing Visions Summit as Stemedica further establishes itself as a leader in the stem cell and biopharmaceutical industries.

About Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies Inc. ( is a specialty biopharmaceutical company that is committed to the development and manufacturing of best-in-class adult stem cells and stem cell factors for use by approved research institutions and hospitals for pre-clinical and human clinical trials. The company is currently developing regulatory pathways for stroke and wound repair. Stemedica is headquartered in San Diego, California.

For more information regarding this Media Release or Stemedica Cell Technologies, contact Dave McGuigan at dmcguigan (at) stemedica (dot) com.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Stemedicas President Delivers Keynote Address at Swiss-Russian Forum
2. Family Research Council: Senator Baucus Undermines President Obamas Abortion Funding Claim
3. AFSCME President McEntee: "Finance Committee Health Care Bill is Deeply Flawed"
4. Cynosure Names Paul Cardarelli Vice President of Business Development
5. Marc Russo Named Vice President of Senior Markets at Blue Shield of California
6. Marc Russo Named Vice President of Individual, Small Group, and Government Business Unit at Blue Shield of California
7. Care Improvement Plus Names Anthony Colistra as Vice President, Market Growth and Development
8. Schofield Media Names Brian Reshefsky Group President
9. Statement from Stuart L. Weinstein, MD, Chairman, Doctors for Medical Liability Reform on President Obamas Health Care Address to Congress
10. Broad Health Coalition Applauds President Obamas Commitment to Medical Liability Reform
11. The Presidents Speech & Mental Health Care
Post Your Comments:
Related Image:
Stemedica's President Delivers Keynote Address At Swiss-Russian Forum 
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... America . ... ... ... ...
(Date:6/23/2016)... , June 23, 2016 The vast majority ... outpatient dialysis facility.  Treatments are usually 3 times a ... per visit, including travel time, equipment preparation and wait ... but especially grueling for patients who are elderly and ... skilled nursing and rehabilitation centers for some duration of ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... rough waters, but it continues to present great opportunities ... featured companies for today: Intrexon Corp. (NYSE: ... ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), ... Learn more about these stocks and receive your complimentary ...
Breaking Medicine Technology: